Lung Transplantation for Lung-Limited Stage IV NSCLC
The DREAM registry study is investigating whether bilateral lung transplantation can be a viable treatment for patients with stage IV non-small cell lung cancer (NSCLC) that is limited to the lungs. Historically, active cancer was a contraindication for transplant, but new research is exploring if highly selected patients might benefit.
Breast Cancer GI Cancer Colorectal Cancer GI Cancer Awareness and Advocacy GU Cancer Bladder Cancer Gyn-Onc Uterine Cancer Awareness Month Gynecologic Cancer Awareness Month Hem/Onc Blood Cancer Awareness Month GVHD Leukemia Lymphoma Myeloproliferative Neoplasms Multiple Myeloma Myelodysplastic Syndrome Myelofibrosis Sickle Cell Immunotherapy More Professional Development Patient Voice Lung Cancer Skin Cancer Other Tumor Types News Treatment Menu Home > Lung Cancer > Lung Transplantation for Lung-Limited Stage IV NSCLC
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in